Magneto-Liposomes as MRI Contrast Agents: A Systematic Study of Different Liposomal Formulations

The majority of the clinically approved iron oxide nanoparticles (IO NPs) used as contrast agents for magnetic resonance imaging (MRI) have been withdrawn from the market either due to safety concerns or lack of profits. To address this challenge, liposomes have been used to prepare IO-based T(2) co...

Descripción completa

Detalles Bibliográficos
Autores principales: Kostevšek, Nina, Cheung, Calvin C. L., Serša, Igor, Kreft, Mateja Erdani, Monaco, Ilaria, Comes Franchini, Mauro, Vidmar, Janja, Al-Jamal, Wafa T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279489/
https://www.ncbi.nlm.nih.gov/pubmed/32384645
http://dx.doi.org/10.3390/nano10050889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279489/
https://www.ncbi.nlm.nih.gov/pubmed/32384645
http://dx.doi.org/10.3390/nano10050889

Ejemplares similares